NCT06169046View on ClinicalTrials.gov

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 13, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Spinal and Bulbar Muscular Atrophy
Interventions
DRUG

Clenbuterol

tablets

DRUG

Placebo

tablets

Trial Locations (1)

35134

RECRUITING

Azienda Ospedale Università di Padova, Padua

All Listed Sponsors
collaborator

Mario Negri Institute for Pharmacological Research

OTHER

lead

Gianni Soraru

OTHER